ImmunityBio, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44.2M | 38.3M | 32.1M | 26.4M | 16.5M | 7.6M | 6.1M | 1.0M |
| Cost of Goods Sold | 238K | 4.2M | 4.1M | 136K | 58K | 0 | 0 | 0 |
| Gross Profit | 44.0M | 34.0M | 27.9M | 26.3M | 16.5M | 7.6M | 6.1M | 1.0M |
| R&D Expenses | 64.8M | 60.8M | 50.7M | 55.2M | 48.2M | 35.2M | 50.4M | 51.1M |
| Operating Expenses | 113.8M | 98.7M | 83.6M | 97.6M | 80.9M | 77.0M | 86.4M | 100.4M |
| Operating Income | -69.8M | -64.7M | -55.6M | -71.3M | -64.4M | -69.4M | -80.3M | -99.3M |
| Other Income / Gains | -563.0M | 2.6M | -11.7M | -21.0M | -65.5M | 10.2M | -5.5M | -35.3M |
| Net Income | -632.8M | -61.9M | -67.3M | -92.6M | -129.6M | -59.2M | -85.7M | -134.6M |
| EPS (Diluted) | -0.62 | -0.063 | -0.071 | -0.10 | -0.15 | -0.08 | -0.12 | -0.20 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.995 | 0.889 | 0.871 | 0.995 | 0.996 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 44.5M | 37.8M | 32.8M | 42.3M | 32.7M | 41.7M | 35.9M | 49.3M |
| Other Expenses | 4.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 114.0M | 103.0M | 87.7M | 97.7M | 80.9M | 77.0M | 86.4M | 100.4M |
| Interest Income | 2.3M | 3.3M | 2.1M | 818K | 520K | 769K | 638K | 833K |
| Interest Expense | 28.5M | 27.2M | 27.6M | 28.9M | 28.9M | 14.9M | 40.2M | 39.0M |
| Depreciation And Amortization | 4.4M | 3.9M | 4.0M | 3.9M | 3.8M | 4.2M | 4.4M | 4.4M |
| Ebitda | -599.9M | -31.0M | -35.8M | -59.5M | -97.2M | -40.1M | -41.1M | -91.2M |
| Ebitdaratio | -13.572 | -0.811 | -1.116 | -2.253 | -5.885 | -5.313 | -6.726 | -87.067 |
| Operating Income Ratio | -1.579 | -1.69 | -1.735 | -2.698 | -3.901 | -9.19 | -13.143 | -94.874 |
| Income Before Tax | -632.8M | -62.1M | -67.3M | -92.3M | -129.9M | -59.2M | -85.8M | -134.6M |
| Income Before Tax Ratio | -14.315 | -1.622 | -2.099 | -3.493 | -7.865 | -7.836 | -14.044 | -128.543 |
| Income Tax Expense | -9K | -135K | -35K | 269K | -234K | 0 | 0 | 0 |
| Net Income Ratio | -14.314 | -1.618 | -2.098 | -3.503 | -7.849 | -7.834 | -14.04 | -128.523 |
| Epsdiluted | -0.62 | -0.063 | -0.071 | -0.10 | -0.15 | -0.09 | -0.12 | -0.20 |
| Weighted Average Shs Out | 1.03B | 989.7M | 946.6M | 888.2M | 853.2M | 733.2M | 695.9M | 686.9M |
| Weighted Average Shs Out Dil | 1.03B | 989.7M | 946.6M | 888.2M | 853.2M | 734.5M | 698.0M | 686.9M |